Ya-Lin A相关文献与解析，生知库 | 链接生命科学的每一步

Low HIV Preexposure Prophylaxis Coverage Among Women: Focused, Innovative Strategies Can Increase Use-United States, 2017-2023

美国女性HIV暴露前预防覆盖率低：有针对性的创新策略可提高使用率——2017-2023年

doi:10.2105/AJPH.2025.308056

Hoover, Karen W; Zhu, Weiming; Hess, Kristen L; Spikes, Pilgrim; Huang, Ya-Lin A; Wiener, Jeffrey; Dunbar, Erica K; Raiford, Jerris L; Collins, Charles B; DiNenno, Elizabeth A; Kourtis, Athena P; Brooks, John T; Fanfair, Robyn Neblett; Courtenay-Quirk, Cari

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis

使用长效注射型暴露前预防药物人群的真实世界 HIV RNA 和抗原/抗体检测

期刊:Clinical Infectious Diseases

影响因子:7.3

doi:10.1093/cid/ciaf173

Zhu, Weiming; Delaney, Kevin; Huang, Ya-Lin A; Patel, Rupa R; Kourtis, Athena P; Hoover, Karen W

Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study-United States, 2019-2023

HIV RNA检测在监测口服暴露前预防药物使用方面的效用有限：一项真实世界队列研究——美国，2019-2023年

期刊:Clinical Infectious Diseases

影响因子:7.3

doi:10.1093/cid/ciaf230

Zhu, Weiming; Delaney, Kevin P; Huang, Ya-Lin A; Patel, Rupa R; Kourtis, Athena P; Hoover, Karen W

Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023

美国“终结艾滋病流行倡议”启动前后，2016-2023年艾滋病毒暴露前预防药物使用趋势

期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes

影响因子:2.2

doi:10.1097/QAI.0000000000003674

Zhu, Weiming; Huang, Ya-Lin A; Kourtis, Athena P; Neblett-Fanfair, Robyn; Mermin, Jonathan; Hoover, Karen W

Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metrics

量化美国可从艾滋病毒暴露前预防（PrEP）中获益的人数：行为指标、基于感染风险指标和经济指标的比较

期刊:

影响因子:

doi:10.1101/2025.09.29.25336900

Rönn, Minttu M; Kourtis, Athena P; Liang, Yizhi; Zheng, Lijia; Puente, Teresa; Huang, Ya-Lin A; Zhu, Weiming; Patel, Rupa R; Wiener, Jeffrey; Hoover, Karen W; Van Handel, Michelle; Menzies, Nicolas A; Salomon, Joshua A

Gaps in guideline adherence: evaluating HLA-B*57:01 screening for abacavir sensitivity and the implementation of evidence-based HIV care

指南遵循方面的差距：评估HLA-B*57:01筛查对阿巴卡韦敏感性的影响以及循证HIV治疗的实施情况

期刊:Clinical Biochemistry

影响因子:

doi:10.1016/j.clinbiochem.2025.110992

Kalman, Lisa V; Xia, Yang; Huang, Ya-Lin A; Buchacz, Kate; Astles, Rex; O'Shea, Jesse

Population Percentage and Population Size of Men Who Have Sex With Men in the United States, 2017-2021: Meta-Analysis of 5 Population-Based Surveys

2017-2021年美国男男性行为者人口比例和人口规模：5项基于人口调查的荟萃分析

期刊:Jmir Public Health and Surveillance

影响因子:3.9

doi:10.2196/56643

Bennett, Brady W; DuBose, Stephanie; Huang, Ya-Lin A; Johnson, Christopher H; Hoover, Karen W; Wiener, Jeffrey; Purcell, David W; Sullivan, Patrick S

发表日期：2024

文献求助收藏

Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008-20: a national cohort study

多替拉韦与2008-2020年美国妊娠结局（包括神经管缺陷）的关系：一项全国性队列研究

期刊:Lancet HIV

影响因子:13

doi:10.1016/S2352-3018(23)00108-X

Kourtis, Athena P; Zhu, Weiming; Lampe, Margaret A; Huang, Ya-Lin A; Hoover, Karen W

发表日期：2023

文献求助收藏

Simplifying Testing for Human Immunodeficiency Virus During Pre-exposure Prophylaxis Monitoring

简化暴露前预防监测期间的人类免疫缺陷病毒检测

Suboptimal laboratory testing at preexposure prophylaxis initiation in the United States

美国暴露前预防启动时的实验室检测不尽如人意

Low HIV Preexposure Prophylaxis Coverage Among Women: Focused, Innovative Strategies Can Increase Use-United States, 2017-2023

美国女性HIV暴露前预防覆盖率低：有针对性的创新策略可提高使用率——2017-2023年

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis

使用长效注射型暴露前预防药物人群的真实世界 HIV RNA 和抗原/抗体检测

Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study-United States, 2019-2023

HIV RNA检测在监测口服暴露前预防药物使用方面的效用有限：一项真实世界队列研究——美国，2019-2023年

Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023

美国“终结艾滋病流行倡议”启动前后，2016-2023年艾滋病毒暴露前预防药物使用趋势

Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metrics

量化美国可从艾滋病毒暴露前预防（PrEP）中获益的人数：行为指标、基于感染风险指标和经济指标的比较

Gaps in guideline adherence: evaluating HLA-B*57:01 screening for abacavir sensitivity and the implementation of evidence-based HIV care

指南遵循方面的差距：评估HLA-B*57:01筛查对阿巴卡韦敏感性的影响以及循证HIV治疗的实施情况

Population Percentage and Population Size of Men Who Have Sex With Men in the United States, 2017-2021: Meta-Analysis of 5 Population-Based Surveys

2017-2021年美国男男性行为者人口比例和人口规模：5项基于人口调查的荟萃分析

Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008-20: a national cohort study

多替拉韦与2008-2020年美国妊娠结局（包括神经管缺陷）的关系：一项全国性队列研究